Drug Shortage Report for APO-BRIMONIDINE
Report ID | 36268 |
Drug Identification Number | 02260077 |
Brand name | APO-BRIMONIDINE |
Common or Proper name | BRIMONIDINE |
Company Name | APOTEX INC |
Market Status | DORMANT |
Active Ingredient(s) | BRIMONIDINE TARTRATE |
Strength(s) | 0.2% |
Dosage form(s) | SOLUTION |
Route of administration | OPHTHALMIC |
Packaging size | 5 ML & 10 ML |
ATC code | S01EA |
ATC description | ANTIGLAUCOMA PREPARATIONS AND MIOTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2018-01-15 |
Estimated end date | 2018-04-09 |
Actual end date | 2018-04-05 |
Shortage status | Resolved |
Updated date | 2018-04-09 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2018-04-09 | French | Compare |
v5 | 2018-04-09 | English | Compare |
v4 | 2018-02-13 | French | Compare |
v3 | 2018-02-13 | English | Compare |
v2 | 2018-01-17 | French | Compare |
v1 | 2018-01-17 | English | Compare |
Showing 1 to 6 of 6